Vanguard Group Inc Xencor Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Vanguard Group Inc holds 7,599,326 shares of XNCR stock, worth $185 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,599,326
Previous 6,996,994
8.61%
Holding current value
$185 Million
Previous $132 Million
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XNCR
# of Institutions
215Shares Held
71.5MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$270 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$222 Million0.14% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$129 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$95.4 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.12MShares$75.8 Million0.17% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.45B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...